194 related articles for article (PubMed ID: 12498769)
1. Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product.
Chan JM; Villarreal G; Jin WW; Stepan T; Burstein H; Wahl SM
Mol Ther; 2002 Dec; 6(6):727-36. PubMed ID: 12498769
[TBL] [Abstract][Full Text] [Related]
2. Long-term suppression of experimental arthritis following intramuscular administration of a pseudotyped AAV2/1-TNFR:Fc Vector.
Sandalon Z; Bruckheimer EM; Lustig KH; Burstein H
Mol Ther; 2007 Feb; 15(2):264-9. PubMed ID: 17235303
[TBL] [Abstract][Full Text] [Related]
3. Preclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion gene.
Zhou X; Shen L; Liu L; Wang C; Qi W; Zhao A; Wu X; Li B
Hum Vaccin Immunother; 2016 Mar; 12(3):732-9. PubMed ID: 26837862
[TBL] [Abstract][Full Text] [Related]
4. Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.
Mease PJ; Hobbs K; Chalmers A; El-Gabalawy H; Bookman A; Keystone E; Furst DE; Anklesaria P; Heald AE
Ann Rheum Dis; 2009 Aug; 68(8):1247-54. PubMed ID: 18678578
[TBL] [Abstract][Full Text] [Related]
5. Modulation of immune and inflammatory responses on experimental arthritis following intraarticular gene transfer of tumor necrosis factor receptor-immunoglobulin Fc.
Zhou X; Gao K; Shen L; Zhao A; Wu X; Wang C; Wang J; Li B
Rheumatol Int; 2012 Sep; 32(9):2605-14. PubMed ID: 21833532
[TBL] [Abstract][Full Text] [Related]
6. Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.
Mease PJ; Wei N; Fudman EJ; Kivitz AJ; Schechtman J; Trapp RG; Hobbs KF; Greenwald M; Hou A; Bookbinder SA; Graham GE; Wiesenhutter CW; Willis L; Ruderman EM; Forstot JZ; Maricic MJ; Dao KH; Pritchard CH; Fiske DN; Burch FX; Prupas HM; Anklesaria P; Heald AE
J Rheumatol; 2010 Apr; 37(4):692-703. PubMed ID: 20032102
[TBL] [Abstract][Full Text] [Related]
7. Intraarticular gene delivery of CTLA4-FasL suppresses experimental arthritis.
Zhang W; Wang F; Wang B; Zhang J; Yu JY
Int Immunol; 2012 Jun; 24(6):379-88. PubMed ID: 22354915
[TBL] [Abstract][Full Text] [Related]
8. Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent.
Adriaansen J; Khoury M; de Cortie CJ; Fallaux FJ; Bigey P; Scherman D; Gould DJ; Chernajovsky Y; Apparailly F; Jorgensen C; Vervoordeldonk MJ; Tak PP
Ann Rheum Dis; 2007 Sep; 66(9):1143-50. PubMed ID: 17363402
[TBL] [Abstract][Full Text] [Related]
9. [Expression of sTNFR-IgGFc fusion gene in endothelial cell and its application in gene therapy for rheumatoid arthritis].
He J; Yao LH; Chen AJ; Yu H; Jia RQ; Cheng CS; Huan LF; Zhang ZQ
Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):378-83. PubMed ID: 16755914
[TBL] [Abstract][Full Text] [Related]
10. Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors.
Sandalon Z; Bruckheimer EM; Lustig KH; Rogers LC; Peluso RW; Burstein H
J Virol; 2004 Nov; 78(22):12355-65. PubMed ID: 15507622
[TBL] [Abstract][Full Text] [Related]
11. AAV2/1-TNFR:Fc gene delivery prevents periodontal disease progression.
Cirelli JA; Park CH; MacKool K; Taba M; Lustig KH; Burstein H; Giannobile WV
Gene Ther; 2009 Mar; 16(3):426-36. PubMed ID: 19078994
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of arthritis by intraarticular dominant negative Ikk beta gene therapy using adeno-associated virus type 5.
Tas SW; Adriaansen J; Hajji N; Bakker AC; Firestein GS; Vervoordeldonk MJ; Tak PP
Hum Gene Ther; 2006 Aug; 17(8):821-32. PubMed ID: 16942442
[TBL] [Abstract][Full Text] [Related]
13. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.
Moreland LW; Baumgartner SW; Schiff MH; Tindall EA; Fleischmann RM; Weaver AL; Ettlinger RE; Cohen S; Koopman WJ; Mohler K; Widmer MB; Blosch CM
N Engl J Med; 1997 Jul; 337(3):141-7. PubMed ID: 9219699
[TBL] [Abstract][Full Text] [Related]
14. Design, expression and characterization of a novel coexpression system of two antiarthritic molecules.
Zhang W; Wang F; Yan J; Zhang X; Wang Y; Jiang Y; Wang L; Xu Y; Yu J
Appl Microbiol Biotechnol; 2013 Jul; 97(14):6301-14. PubMed ID: 23463251
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with TNFR-Fc and CTLA4-FasL using the recombinant adeno-associated virus potently suppresses adjuvant-induced arthritis in rats.
Wang F; Yu J; Wang Y; Jiang Y; Guo N; Zhang W
Appl Microbiol Biotechnol; 2015 Aug; 99(15):6327-37. PubMed ID: 25707864
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritis.
Murray KM; Dahl SL
Ann Pharmacother; 1997 Nov; 31(11):1335-8. PubMed ID: 9391689
[TBL] [Abstract][Full Text] [Related]
17. TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis.
Mukherjee P; Wu B; Mayton L; Kim SH; Robbins PD; Wooley PH
Ann Rheum Dis; 2003 Aug; 62(8):707-14. PubMed ID: 12860724
[TBL] [Abstract][Full Text] [Related]
18. Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis.
Childs LM; Goater JJ; O'Keefe RJ; Schwarz EM
J Bone Joint Surg Am; 2001 Dec; 83(12):1789-97. PubMed ID: 11741056
[TBL] [Abstract][Full Text] [Related]
19. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
20. Intraarticular gene transfer of SPRY2 suppresses adjuvant-induced arthritis in rats.
Zhang W; Zhu J; Du Z; Yu J; Xu Y; Wang F
Appl Microbiol Biotechnol; 2015 Aug; 99(16):6727-35. PubMed ID: 25935347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
